-+ 0.00%
-+ 0.00%
-+ 0.00%

ONKURE THERAPEUTICS: $96.7 MLN CASH & CASH EQUIVALENTS SUFFICIENT TO FUND OPS INTO Q4 2026

Reuters·05/06/2025 11:38:58

Please log in to view news